Biogen Positions Itself For The Future

Biogen's (BIIB) product portfolio continues to grow, and the future looks good as well: High capital returns and investments that are poised to generate growth in the future provide a good long term outlook. Due to a relatively low valuation shares look attractive.

Biogen's second quarter results start and end with a double beat on the top and the bottom line:

READ FULL ARTICLE HERE

Recent Deals

Interested in advertising your deals? Contact Edwin Warfield.